{
    "clinical_study": {
        "@rank": "154891", 
        "acronym": "Prodigy-I", 
        "arm_group": {
            "arm_group_label": "Burst stimulation", 
            "description": "At permanent implant with the Prodigy system, patients will be programmed with Burst stimulation"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to confirm long term efficacy and safety of the ProdigyTM\n      neuromodulation system in the management of failed back surgery syndrome or chronic\n      intractable pain of the trunk and/or limbs."
        }, 
        "brief_title": "A Post-market Study Evaluating the Prodigy Neuromodulation System for the Management of Failed Back Surgery Syndrome or Chronic Intractable Pain of the Trunk and/or Limbs.", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Pain", 
        "condition_browse": {
            "mesh_term": [
                "Pain, Intractable", 
                "Failed Back Surgery Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient with chronic, intractable pain of the trunk and/or limbs, including\n             unilateral or bilateral pain associated with the following: failed back surgery\n             syndrome or intractable low back and/or leg pain\n\n          -  Patient is considered by the investigator as a candidate for implantation of a SCS\n             system\n\n          -  Patient is \u2265 18 years of age\n\n          -  Patient must be willing and able to comply with study requirements\n\n          -  Patient must indicate his/her understanding of the study and willingness to\n             participate by signing an appropriate Informed Consent Form\n\n        Exclusion Criteria:\n\n          -  Patient is immune-compromised\n\n          -  Patient has history of cancer requiring active treatment in the last 6 months\n\n          -  Patient has a documented history of substance abuse (narcotics, alcohol, etc.) or\n             substance dependency in the last 6 months\n\n          -  Patients with a SCS system or implantable infusion pump implanted previously\n\n          -  Patient has a life expectancy of less than one year\n\n          -  Patient is pregnant or is planning to become pregnant during the duration of the\n             investigation\n\n          -  Patient is unable to comply with the follow up schedule\n\n          -  Patient needing legally authorized representative\n\n          -  Patient unable to read and write\n\n          -  Patient is currently participating in another clinical investigation with an active\n             treatment arm"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients who are indicated for Spinal Cord Stimulation (SCS) and with Failed Back Surgery\n        Syndrome or Chronic Intractable Pain of the Trunk and/or Limbs."
            }
        }, 
        "enrollment": {
            "#text": "123", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02143791", 
            "org_study_id": "NM-13-038-ID-SC"
        }, 
        "intervention": [
            {
                "arm_group_label": "Burst stimulation", 
                "intervention_name": "Burst stimulation", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Burst stimulation", 
                "intervention_name": "Prodigy system", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "SCS", 
            "Burst stimulation"
        ], 
        "lastchanged_date": "May 20, 2014", 
        "number_of_groups": "1", 
        "official_title": "A Post-market Study Evaluating the Prodigy Neuromodulation System for the Management of Failed Back Surgery Syndrome or Chronic Intractable Pain of the Trunk and/or Limbs.", 
        "overall_contact": {
            "email": "rdiaz@sjm.com", 
            "last_name": "Roni Diaz", 
            "phone": "+1 972 309 8601"
        }, 
        "overall_contact_backup": {
            "email": "mvanbree@sjm.com", 
            "last_name": "Monique Van Bree", 
            "phone": "+3227746947"
        }, 
        "overall_official": [
            {
                "affiliation": "St Augustinus, Wilrijk, Belgium", 
                "last_name": "Tony Van Havenbergh", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "St. Jude Medical", 
                "last_name": "Roni Diaz", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The primary endpoint is the percentage of pain relief at the 3-month visit compared to baseline visit, as measured by the Visual Analog Scale (VAS).", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02143791"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Rate of serious adverse events (SAEs) and/or procedure/device-related adverse events ((S)ADEs)", 
            "safety_issue": "Yes", 
            "time_frame": "from enrollment to 12 months follow up"
        }, 
        "source": "St. Jude Medical", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "St. Jude Medical", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}